Zobrazeno 1 - 10
of 25
pro vyhledávání: '"Mikail Gögenur"'
Autor:
Susanne Brix, Ismail Gögenur, Mustafa Bulut, Lasse Bremholm Hansen, Mikail Gögenur, Lukas Balsevicius, Nesibe Colak, Tobias Freyberg Justesen, Anne-Marie Kanstrup Fiehn, Marianne Bøgevang Jensen, Kathrine Høst-Rasmussen, Britt Cappelen, Shruti Gaggar, Asma Tajik, Jawad Ahmad Zahid, Astrid Louise Bjørn Bennedsen, Tommaso Del Buono D’Ondes, Hans Raskov, Susanne Gjørup Sækmose, Ali Salanti
Publikováno v:
Journal for ImmunoTherapy of Cancer, Vol 11, Iss 5 (2023)
Background In colorectal cancer, the effects of immune checkpoint inhibitors are mostly limited to patients with deficient mismatch repair tumors, characterized by a high grade infiltration of CD8+T cells. Interventions aimed at increasing intratumor
Externí odkaz:
https://doaj.org/article/94c6d0a449c0483fae25a919b3acb501
Autor:
Andreas W. Rosen, Mikail Gögenur, Isabella W. Paulsen, Jesper Olsen, Susanne Eiholm, Lene T. Kirkeby, Ole B. Pedersen, Niels Pallisgaard, Ismail Gögenur
Publikováno v:
BMC Gastroenterology, Vol 22, Iss 1, Pp 1-8 (2022)
Abstract Background Various conditions with cellular decay are associated with elevated cell-free DNA (cfDNA). This study aimed to investigate if perioperatively measured cfDNA levels were associated with the surgical approach, complications, or recu
Externí odkaz:
https://doaj.org/article/3d17e8a97102452290d2dd9a59ce148a
Autor:
Tenna V. Henriksen, Thomas Reinert, Emil Christensen, Himanshu Sethi, Karin Birkenkamp‐Demtröder, Mikail Gögenur, Ismail Gögenur, Bernhard G. Zimmermann, The IMPROVE Study Group, Lars Dyrskjøt, Claus L. Andersen
Publikováno v:
Molecular Oncology, Vol 14, Iss 8, Pp 1670-1679 (2020)
Detection of circulating tumor DNA (ctDNA) post‐treatment is an emerging marker of residual disease. ctDNA constitutes only a minor fraction of the cell‐free DNA (cfDNA) circulating in cancer patients, complicating ctDNA detection. This is exacer
Externí odkaz:
https://doaj.org/article/1a0853f72d514abf8dadcf4dce6648a3
Publikováno v:
PeerJ, Vol 5, p e4033 (2017)
Background The perioperative period is important for patient outcome. Colorectal cancer surgery can lead to metastatic disease due to release of disseminated tumor cells and the induction of surgical stress response. To explore the overall effects on
Externí odkaz:
https://doaj.org/article/0a80a10e3ad8449bb9ce23e27f8f599e
Autor:
Karoline B. Bräuner, Andreas W. Rosen, Adamantia Tsouchnika, Julie S. Walbech, Mikail Gögenur, Viviane A. Lin, Johan S. R. Clausen, Ismail Gögenur
Publikováno v:
Bräuner, K B, Rosen, A W, Tsouchnika, A, Walbech, J S, Gögenur, M, Lin, V A, Clausen, J S R & Gögenur, I 2022, ' Developing prediction models for short-term mortality after surgery for colorectal cancer using a Danish national quality assurance database ', International Journal of Colorectal Disease, vol. 37, no. 8, pp. 1835-1843 . https://doi.org/10.1007/s00384-022-04207-6
Purpose The majority of colorectal cancer surgeries are performed electively, and treatment is often decided at the multidisciplinary team conference. Although the average 30-day mortality rate is low, there is substantial population heterogeneity fr
Publikováno v:
Applied Immunohistochemistry & Molecular Morphology. 30:493-500
Colorectal cancer (CRC) is the third most common cancer worldwide. Although clinical outcome varies among patients diagnosed within the same TNM stage it is the cornerstone in treatment decisions as well as follow-up programmes. Tumor-infiltrating ly
Autor:
Tobias Freyberg Justesen, Mikail Gögenur, Johan Stub Rønø Clausen, Maliha Mashkoor, Andreas Weinberger Rosen, Ismail Gögenur
Publikováno v:
European Journal of Surgical Oncology.
Autor:
Jonas Kabel, Tenna Vesterman Henriksen, Christina Demuth, Amanda Frydendahl, Mads Heilskov Rasmussen, Jesper Nors, Nicolai J. Birkbak, Anders Husted Madsen, Uffe S. Løve, Per Vadgaard Andersen, Thomas Kolbro, Alessio Monti, Ole Thorlacius-Ussing, Mikail Gögenur, Jeppe Kildsig, Nis Hallundbæk Schlesinger, Peter Bondeven, Lene Hjerrild Iversen, Kåre Andersson Gotschalck, Claus Lindbjerg Andersen
Publikováno v:
Cancers
Volume 15
Issue 4
Pages: 1136
Kabel, J, Henriksen, T V, Demuth, C, Frydendahl, A, Rasmussen, M H, Nors, J, Birkbak, N J, Madsen, A H, Løve, U S, Andersen, P V, Kolbro, T, Monti, A, Thorlacius-Ussing, O, Gögenur, M, Kildsig, J, Schlesinger, N H, Bondeven, P, Iversen, L H, Gotschalck, K A & Andersen, C L 2023, ' Impact of Whole Genome Doubling on Detection of Circulating Tumor DNA in Colorectal Cancer ', Cancers, vol. 15, no. 4, 1136 . https://doi.org/10.3390/cancers15041136
Volume 15
Issue 4
Pages: 1136
Kabel, J, Henriksen, T V, Demuth, C, Frydendahl, A, Rasmussen, M H, Nors, J, Birkbak, N J, Madsen, A H, Løve, U S, Andersen, P V, Kolbro, T, Monti, A, Thorlacius-Ussing, O, Gögenur, M, Kildsig, J, Schlesinger, N H, Bondeven, P, Iversen, L H, Gotschalck, K A & Andersen, C L 2023, ' Impact of Whole Genome Doubling on Detection of Circulating Tumor DNA in Colorectal Cancer ', Cancers, vol. 15, no. 4, 1136 . https://doi.org/10.3390/cancers15041136
Objective: Circulating tumor DNA (ctDNA) is a candidate biomarker of cancer with practice-changing potential in the detection of both early and residual disease. Disease stage and tumor size affect the probability of ctDNA detection, whereas little i
Autor:
Mikail Gögenur, Lukas Balsevicius, Mustafa Bulut, Nesibe Colak, Tobias Freyberg Justesen, Anne-Marie Kanstrup Fiehn, Marianne Bøgevang Jensen, Kathrine Høst-Rasmussen, Britt Cappelen, Shruti Gaggar, Asma Tajik, Jawad Ahmad Zahid, Astrid Louise Bjørn Bennedsen, Tommaso Del Buono D’Ondes, Hans Raskov, Susanne Gjørup Sækmose, Lasse Bremholm Hansen, Ali Salanti, Susanne Brix, Ismail Gögenur
Publikováno v:
Gögenur, M, Balsevicius, L, Bulut, M, Colak, N, Justesen, T F, Fiehn, A-M K, Jensen, M B, Høst-Rasmussen, K, Cappelen, B, Gaggar, S, Tajik, A, Zahid, J A, Bennedsen, A L B, D'Ondes, T D B, Raskov, H, Sækmose, S G, Hansen, L B, Salanti, A, Brix, S & Gögenur, I 2023, ' Neoadjuvant intratumoral influenza vaccine treatment in patients with proficient mismatch repair colorectal cancer leads to increased tumor infiltration of CD8+ T cells and upregulation of PD-L1: a phase 1/2 clinical trial ', Journal for ImmunoTherapy of Cancer, vol. 11, no. 5, e006774 . https://doi.org/10.1136/jitc-2023-006774
BackgroundIn colorectal cancer, the effects of immune checkpoint inhibitors are mostly limited to patients with deficient mismatch repair tumors, characterized by a high grade infiltration of CD8+T cells. Interventions aimed at increasing intratumora
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::60f85e690fee350b864f70c666637cc7
https://orbit.dtu.dk/en/publications/53ac1b78-d29d-4cff-95bd-e42a69c92f71
https://orbit.dtu.dk/en/publications/53ac1b78-d29d-4cff-95bd-e42a69c92f71
Autor:
Mikail Gögenur, Mustafa Bulut, Senior Resident, Lukas Balsevicius, Anne-Marie Kanstrup Fiehn, Marianne Bøgevang Jensen, Nesibe Özgur Colak, Tobias Freyberg Justesen, Paulo Cesar Martins Urbano, Lasse Bremholm Hansen, Chief Surgeon, Ismail Gögenur
Publikováno v:
Regular and Young Investigator Award Abstracts.